Pengxin Dong

At SiPhox Health, our mission is to tackle the problem of chronic diseases by enabling new Direct-to-Consumer health and wellness solutions. With six out of ten Americans living with chronic conditions, we’re dedicated to revolutionizing health diagnostics with next-generation infrastructure for home use. SiPhox was founded by MIT scientists Michael Dubrovsky and Diedrik Vermeulen to integrate microfluidics and biochemistry with Silicon Photonics to miniaturize protein and hormone testing. As we work on building advanced home diagnostic devices, we are creating the most comprehensive at-home test kit on the market, providing valuable health insights and actionable plans to help achieve health goals. The entire SiPhox team is driven by a shared passion: combating the chronic disease epidemic. We envision a future where staying healthy is not only affordable and convenient but also enjoyable for everyone. This mission is deeply personal to us – its about our own well-being, the health of our families, and the prosperity of humanity as a whole.

Sabanci Climate Ventures fuels innovation at the forefront of climate solutions. We invest in visionary startups across the US and Europe, empowering them to build groundbreaking businesses that redefine the energy value chain. Leveraging Sabancis established expertise, we bridge the gap between emerging and developed markets. We foster collaboration between Sabanci companies and our portfolio, piloting and scaling promising solutions. Our investments target high-impact sectors – from energy storage and smart grids to sustainable software and clean energy generation. We focus on Series A and B stages, maximizing value creation for both startups and Sabanci. Selective Seed investments target potential game-changers, while rare Series C placements unlock strategic partnerships. We allocate a portion of the fund to strategic partnerships, ensuring access to a broader flow of innovative deals. Our focus is on US and European ecosystems, hubs for clean technology advancement.

At SiPhox Health, our mission is to tackle the problem of chronic diseases by enabling new Direct-to-Consumer health and wellness solutions. With six out of ten Americans living with chronic conditions, we’re dedicated to revolutionizing health diagnostics with next-generation infrastructure for home use. SiPhox was founded by MIT scientists Michael Dubrovsky and Diedrik Vermeulen to integrate microfluidics and biochemistry with Silicon Photonics to miniaturize protein and hormone testing. As we work on building advanced home diagnostic devices, we are creating the most comprehensive at-home test kit on the market, providing valuable health insights and actionable plans to help achieve health goals. The entire SiPhox team is driven by a shared passion: combating the chronic disease epidemic. We envision a future where staying healthy is not only affordable and convenient but also enjoyable for everyone. This mission is deeply personal to us – its about our own well-being, the health of our families, and the prosperity of humanity as a whole.

Anzu Partners is a venture capital and private equity firm that invests in breakthrough industrial technologies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. Anzu Partners has offices in Washington, DC, San Diego, CA, Boston, MA, Atlanta, GA, and Tampa, FL.

As a hub of technology and innovation within Germany, Bavaria is one of the premier locations for up-and-coming high-tech companies and venture capital professionals in Europe. Since 1995, Bayern Kapital has been supporting young Bavarian technology companies with venture and growth capital, a long-term perspective and access to a wide-reaching network. As one of the most experienced and financially strong venture capital investors in the DACH region and Europe, we support companies from seed phase to exit or IPO – and throughout growth, scale-up, expansion and internationalization. With investments of up to EUR 50 million per company, we help Bavarian innovators turn their business ideas into internationally successful businesses.

Dr. Yu Consulting and Investment GmbH (Yu Advisory) was founded by Dr. Dahai Yu, previous executive board member of one of the world’s leading specialty chemicals company - Evonik Industries. We provide a unique business model by directly investing in private companies, while advising and supporting them to grow faster in a sustainable way in European and Asian markets. We value a long-term commitment rather than a short-term exit approach, cooperate closely with world-class private equity and other investment firms to unlock the potential of our portfolio companies. In addition, we also provide advisory services in VC& FE funds and cross-border M&A deals.